Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Genet Mol Res ; 14(1): 2241-52, 2015 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-25867371

RESUMO

The purpose of this research was to characterize an olive core collection using some agronomic characters and simple sequence repeat (SSR) markers and to determine SSR markers associated with the content of fatty acids in olive oil. SSR marker analysis demonstrated the presence of a high amount of genetic variation between the olive cultivars analyzed. A UPGMA dendrogram demonstrated that olive cultivars did not cluster on the basis of their geographic origin. Fatty acid components of olive oil in these cultivars were determined. The results also showed that there was a great amount of variation between the olive cultivars in terms of fatty acid composition. For example, oleic acid content ranged from 57.76 to 76.9% with standard deviation of 5.10%. Significant correlations between fatty acids of olive oil were observed. For instance, a very high negative correlation (-0.812) between oleic and linoleic acids was detected. A structured association analysis between the content of fatty acids in olive oil and SSR markers was performed. STRUCTURE analysis assigned olive cultivars to two gene pools (K = 2). Assignment of olive cultivars to these gene pools was not based on geographical origin. Association between fatty acid traits and SSR markers was evaluated using the general linear model of TASSEL. Significant associations were determined between five SSR markers and stearic, oleic, linoleic, and linolenic acids of olive oil. Very high associations (P < 0.001) between ssrOeUA-DCA14 and stearic acid and between GAPU71B and oleic acid indicated that these markers could be used for marker-assisted selection in olive.


Assuntos
Ácidos Graxos/metabolismo , Variação Genética , Repetições de Microssatélites/genética , Olea/genética , Olea/metabolismo , Azeite de Oliva/metabolismo , Alelos , Análise por Conglomerados , Frequência do Gene , Genótipo , Olea/classificação , Azeite de Oliva/química , Fenótipo , Polimorfismo Genético , Especificidade da Espécie
2.
Genet Mol Res ; 14(1): 2762-74, 2015 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-25867425

RESUMO

The purpose of this study was to characterize olive core collection with amplified fragment length polymorphism (AFLP) markers and fruit traits and to determine AFLP markers significantly associated with these fruit characters in olive. A total of 168 polymorphic AFLP markers generated by five primer combinations and nine fruit traits were used to characterize relationships between 18 olive cultivars. Although all olive cultivars were discriminated from each other by either AFLP markers (<0.75 similarity level) or fruit traits, clustering based on the AFLP markers and fruit traits was not significantly correlated (r = 0.13). Partial clustering of olive cultivars by AFLP markers according to their geographical origin was observed. Associations of AFLP markers with fruits were determined using a multiple-regression analysis with stepwise addition of AFLP markers. Significant associations between eight AFLP markers and fruit traits were identified. While five AFLP markers demonstrated significant negative correlation with fruit and stone weight, width and length and total polyphenols (P < 0.05), three AFLP markers displayed significant positive correlation with α-tocopherol and γ-tocopherol (P < 0.01). This is the first report on the association of molecular markers with fruit traits in olive. Molecular markers associated with morphological and agronomic traits could be utilized for the breeding of olive cultivars. However, the association power of these markers needs to be confirmed in larger populations, and highly correlated markers should then be converted to PCR-based DNA markers such as sequence-characterized amplified region markers for better utilization.


Assuntos
Análise do Polimorfismo de Comprimento de Fragmentos Amplificados/métodos , Frutas/genética , Marcadores Genéticos/genética , Olea/genética , Análise por Conglomerados , DNA de Plantas/genética , Frutas/metabolismo , Olea/classificação , Olea/metabolismo , Polimorfismo Genético , Análise de Regressão , alfa-Tocoferol/metabolismo , gama-Tocoferol/metabolismo
3.
Cell Biol Int ; 33(11): 1165-72, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19716895

RESUMO

Possible synergistic cytotoxic and apoptotic effects of gossypol with zoledronic acid on DU-145 cells were explored, along with the rationale behind any observed synergism due to the different apoptotic proteins involved. XTT cell proliferation assay was used to assess the cytotoxicity, and DNA fragmentation and caspase 3/7 activity were measured to verify apoptosis. Human Apoptosis Array was used to evaluate apoptotic proteins. The synergistic cytotoxic combination treatment had a versatile effect on apoptotic proteins, through inhibition of anti-apoptotic proteins (including cIAP-1, cIAP-2, survivin, livin, claspin, p53, p21, PON-2 and heat shock proteins) and concurrently the induction of pro-apoptotic proteins (Bad, Bax, Fas, FADD, cleaved caspase-3 and p27). Both drugs had a minimal toxicity profile comparing to cytotoxic agents. Combination treatments targeting many pivotal apoptosis-related proteins may be a rationale option for treatment of prostate cancer.


Assuntos
Apoptose/efeitos dos fármacos , Difosfonatos/farmacologia , Gossipol/farmacologia , Imidazóis/farmacologia , Neoplasias da Próstata/tratamento farmacológico , Proteínas Reguladoras de Apoptose/metabolismo , Conservadores da Densidade Óssea/farmacologia , Conservadores da Densidade Óssea/uso terapêutico , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Anticoncepcionais Masculinos/farmacologia , Anticoncepcionais Masculinos/uso terapêutico , Fragmentação do DNA/efeitos dos fármacos , Difosfonatos/uso terapêutico , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Sinergismo Farmacológico , Gossipol/uso terapêutico , Hormônios/metabolismo , Humanos , Imidazóis/uso terapêutico , Masculino , Neoplasias da Próstata/patologia , Ácido Zoledrônico
4.
Cell Biol Int ; 33(2): 239-46, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19103299

RESUMO

Docetaxel, a semi-synthetic taxane analogue, is used effectively in the treatment of metastatic prostate cancer. Zoledronic acid, the most potent member of bisphosphonates, has shown pleiotropic anti-tumoral effects on prostate cancer cells. We have explored the possible additive/synergistic effects and the apoptotic pathways induced by combination treatment of docetaxel and zoledronic acid in hormone and drug refractory, PC-3 and DU-145 prostate cancer cells. Combination of docetaxel and zoledronic acid synergistically inhibits cell growth in PC-3 and DU-145 cells. Moreover, this effect was due to downregulation of antiapoptotic protein Bcl-2 in PC-3 and DU-145 cells. In conclusion, docetaxel/zoledronic acid combination is potentially a novel and effective approach for the treatment of prostate cancer.


Assuntos
Antineoplásicos/farmacologia , Apoptose , Difosfonatos/farmacologia , Imidazóis/farmacologia , Neoplasias da Próstata/tratamento farmacológico , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Taxoides/farmacologia , Androgênios/fisiologia , Antineoplásicos/uso terapêutico , Caspase 3/metabolismo , Caspase 7/metabolismo , Linhagem Celular Tumoral , Fragmentação do DNA/efeitos dos fármacos , Difosfonatos/uso terapêutico , Docetaxel , Regulação para Baixo , Resistencia a Medicamentos Antineoplásicos , Sinergismo Farmacológico , Humanos , Imidazóis/uso terapêutico , Masculino , Neoplasias da Próstata/metabolismo , Taxoides/uso terapêutico , Ácido Zoledrônico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...